While a specific targeted therapy showed no influence ( Figure S2A ), line of therapy showed a borderline significance with the tendency for a benefit if immunotherapy was given as a 1st-line treatment ( Figure S2B ).
← all excerpts
Acute Phase Proteins as Early Predictors for Immunotherapy Response in Advanced NSCLC: An Explorative Study.
1
—
—